154 related articles for article (PubMed ID: 2501071)
1. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
Odom RB
Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
Bork K; Brauers J; Kresken M
Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
[TBL] [Abstract][Full Text] [Related]
3. Topical mupirocin in the treatment of bacterial skin infections.
Rumsfield J; West DP; Aronson IK
Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
[TBL] [Abstract][Full Text] [Related]
4. Mupirocin: a topical antibiotic with a unique structure and mechanism of action.
Parenti MA; Hatfield SM; Leyden JJ
Clin Pharm; 1987 Oct; 6(10):761-70. PubMed ID: 3146455
[TBL] [Abstract][Full Text] [Related]
5. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
Morley PA; Munot LD
Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
[TBL] [Abstract][Full Text] [Related]
6. Topical mupirocin treatment of impetigo is equal to oral erythromycin therapy.
Mertz PM; Marshall DA; Eaglstein WH; Piovanetti Y; Montalvo J
Arch Dermatol; 1989 Aug; 125(8):1069-73. PubMed ID: 2502950
[TBL] [Abstract][Full Text] [Related]
7. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
Wong KS; Lim KB; Tham SN; Ling ML; Tan T
Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312
[TBL] [Abstract][Full Text] [Related]
8. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
Gilbert M
J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
[TBL] [Abstract][Full Text] [Related]
10. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Ward A; Campoli-Richards DM
Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
[TBL] [Abstract][Full Text] [Related]
11. Review of mupirocin ointment in the treatment of impetigo.
Leyden JJ
Clin Pediatr (Phila); 1992 Sep; 31(9):549-53. PubMed ID: 1468173
[TBL] [Abstract][Full Text] [Related]
12. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections].
Colin M; Avon P
Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741
[TBL] [Abstract][Full Text] [Related]
13. Topical antibiotic treatment of impetigo with mupirocin.
Eells LD; Mertz PM; Piovanetti Y; Pekoe GM; Eaglstein WH
Arch Dermatol; 1986 Nov; 122(11):1273-6. PubMed ID: 3096221
[TBL] [Abstract][Full Text] [Related]
14. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
White DG; Collins PO; Rowsell RB
J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
[TBL] [Abstract][Full Text] [Related]
15. Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic.
Gould PW; Villiger JW
N Z Med J; 1986 Jul; 99(805):516. PubMed ID: 3090486
[No Abstract] [Full Text] [Related]
16. Topical mupirocin vs. systemic erythromycin treatment for pyoderma.
McLinn S
Pediatr Infect Dis J; 1988 Nov; 7(11):785-90. PubMed ID: 3148127
[TBL] [Abstract][Full Text] [Related]
17. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
Johnston C
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
[No Abstract] [Full Text] [Related]
18. Mupirocin and the eradication of Staphylococcus aureus in atopic dermatitis.
Luber H; Amornsiripanitch S; Lucky AW
Arch Dermatol; 1988 Jun; 124(6):853-4. PubMed ID: 3132108
[No Abstract] [Full Text] [Related]
19. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections.
Buchvald J
J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonic acid--a new antibiotic for skin infections.
Reilly GD; Spencer RC
J Antimicrob Chemother; 1984 Mar; 13(3):295-8. PubMed ID: 6427173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
